George Washington University

Running trials

• Recruiting

  Colorectal Cancer Screening in the Homeless

  NCT07220018· George Washington University· Source

• Recruiting

  Feasibility of Remote Monitoring of Patients With Myasthenia Gravis

  NCT07787247· George Washington University· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

  NCT07284849· Phase 3· Incyte Corporation· Source

• Recruiting

  How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types

  NCT06691100· George Washington University· Source

• Recruiting

  Social & QoL Behaviors in Parkinson's Disease

  NCT06385184· Gregory Wallace· Source

• Recruiting

  A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

  NCT06064877· Phase 3· AVEO Pharmaceuticals, Inc.· Source

• Recruiting

  CtDNA Based MRD Testing for NAC Monitoring in TNBC

  NCT06230185· Personalis Inc.· Source

• Recruiting

  MuSK Myasthenia 1000 Study

  NCT06259071· George Washington University· Source

• Recruiting

  Artificial Intelligence for Brain MRI Analysis in Epilepsy

  NCT07881185· Istituto Giannina Gaslini· Source

• Recruiting

  Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

  NCT05663502· AIDS Malignancy Consortium· Source

• Active, not recruiting

  Parent-focused Intervention to Reduce HIV Risk in Gay and Bisexual Adolescents

  NCT05852600· George Washington University· Source

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study

  NCT04949464· AIDS Malignancy Consortium· Source

• Active, not recruiting

  A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment

  NCT05455320· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

  NCT05533697· Phase 1/2· ModernaTX, Inc.· Source

• Recruiting

  Erector Spinae Block for Thoracic Surgery

  NCT05521789· Phase 4· George Washington University· Source

• Recruiting

  Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

  NCT05135091· Phase 3· Neurona Therapeutics· Source

• Active, not recruiting

  HEALEY ALS Platform Trial - Master Protocol

  NCT04297683· Phase 2/3· Merit E. Cudkowicz, MD· Source

• Enrolling by invitation

  Genetic Education in BRCA Families

  NCT03544983· Georgetown University· Source

• Active, not recruiting

  Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial

  NCT03947619· Abiomed Inc.· Source

• Recruiting

  Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI

  NCT03474029· Phase 2/3· Centers for Disease Control and Prevention· Source

• Active, not recruiting

  A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

  NCT03661866· Target PharmaSolutions, Inc.· Source

• Active, not recruiting

  Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates

  NCT03674307· University of British Columbia· Source

• Active, not recruiting

  Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV

  NCT02016924· Phase 2/3· Gilead Sciences· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer2 recruiting
• Epilepsy2 recruiting
• HIV2 recruiting
• Myasthenia gravis2 recruiting
• Childhood cancers1 recruiting
• Head and neck cancer1 recruiting
• Lung cancer1 recruiting
• Obesity1 recruiting
• Ovarian cancer1 recruiting
• Parkinson disease1 recruiting
• Prostate cancer1 recruiting
• Sarcoma1 recruiting
• Triple-negative breast cancer1 recruiting
• Tuberculosis1 recruiting

Closed trials

• Completed

  Juntas Adelante: A Peer-Coaching Intervention to Promote Chemoprophylaxis for HIV Prevention Among Latina Transgender Women in the Washington DC Metropolitan Area.

  NCT07808541· George Washington University· Source

• Completed

  Brain Health & the Microbiome

  NCT06039267· George Washington University· Source

• Completed

  POC Study to Evaluate BSI-045B in Moderate-to-severe Atopic Dermatitis

  NCT05932654· Phase 2· Biosion, Inc.· Source

• Withdrawn

  Telemonitoring to Treat Group 2 Pulmonary Hypertension

  NCT04882774· Phase 2· Mardi Gomberg -Maitland MD, MSc· Source

• Completed

  Uncontrolled Hypertension Among the Homeless

  NCT05187013· George Washington University· Source

• Completed

  SPI-1005 for the Treatment of Meniere's Disease

  NCT04677972· Phase 3· Sound Pharmaceuticals, Incorporated· Source

• Completed

  Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)

  NCT05172024· NYU Langone Health· Source

• Completed

  Exploring Outcomes and Characteristics of Myasthenia Gravis 2

  NCT06002945· Yale University· Source

• Withdrawn

  Diet, Physical Activity and Body Composition Changes During R-CHOP

  NCT04293900· George Washington University· Source

• Completed

  Light Treatment Effectiveness (LITE) Study

  NCT03726489· University of Pennsylvania· Source

• Completed

  BAROSTIM NEO Hypertension Pivotal Trial

  NCT01679132· CVRx, Inc.· Source

Conditions

Diseases this institution publishes on or runs trials for.

• HIV174 works · 5 trials
• Obesity119 works · 1 trial
• Atopic dermatitis (eczema)84 works · 2 trials
• Epilepsy40 works · 2 trials
• Psoriasis34 works · 2 trials
• Sickle cell disease26 works · 0 trials
• Congenital heart disease25 works · 0 trials
• Autism25 works · 0 trials
• Myasthenia gravis17 works · 3 trials
• Hidradenitis suppurativa17 works · 1 trial
• Obstructive sleep apnoea16 works · 0 trials
• Pulmonary arterial hypertension16 works · 1 trial
• Long COVID and ME/CFS12 works · 1 trial
• Childhood cancers10 works · 1 trial
• Hepatitis C9 works · 0 trials
• Meningioma9 works · 0 trials
• Cerebral palsy8 works · 0 trials
• Sarcoidosis7 works · 0 trials
• Hydrocephalus7 works · 0 trials
• Alopecia areata6 works · 1 trial
• Lyme disease5 works · 0 trials
• Turner syndrome5 works · 0 trials
• Polycystic kidney disease3 works · 0 trials